文献速递心血管胸部CT

术前心脏CTA衍生的左心房功能与容积参数在预测经导管主动脉瓣置换术后死亡率中的效用

Utility of Functional and Volumetric Left Atrial Parameters Derived From Preprocedural Cardiac CTA in Predicting Mortality After Transcatheter Aortic Valve Replacement.
PubMed 文献 · AJR Am J Roentgenol · 2021-10-13

本回顾性研究纳入175例接受TAVR的重度主动脉瓣狭窄患者,利用术前心脏CTA测量左心房最大/最小容积指数(LAVImax、LAVImin)和左心房排空分数(LAEF)。中位随访21个月期间38例(21.7%)死亡;校正临床参数后仅LAEF独立预测死亡(HR 0.97,95%CI 0.94-0.99,p=.02)。将LAEF加入STS-PROM模型后C指数从0.636升至0.700。

要点

  • 术前心脏CTA可自动计算LAEF,校正临床参数后LAEF独立预测TAVR术后死亡(HR 0.97,p=.02)。
  • LAVImax、LAVImin在单变量分析中预测死亡(HR均为1.02,p=.01和p<.001),多变量校正后未达独立预测。
  • 将LAEF加入STS-PROM模型使C指数从0.636升至0.700,或可改善术后风险分层。

核心结论

  • 术前心脏CTA衍生的LAEF独立预测重度AS患者TAVR术后死亡;LAVImax、LAVImin单变量预测死亡,但校正临床参数后仅LAEF独立预测。

研究设计与样本

  • 回顾性研究,纳入175例重度AS患者(92男、83女;中位年龄79.0岁),均因临床术前评估接受心脏CTA;由博士后研究员用双平面面积-长度法测量最大和最小左心房容积并计算LAVImax与LAVImin,LAEF自动计算;记录TAVR术后24个月内全因死亡;采用Cox回归(报告HR和95%CI)和Harrell C指数评估模型;放射科住院医师在20%(n=35)随机样本中重复测量,用ICC评估观察者间一致性。

诊断标准与关键数值

  • 单变量Cox回归:LAVImax HR 1.02(95%CI 1.01-1.04),p=.01;LAVImin HR 1.02(95%CI 1.01-1.04),p<.001;LAEF HR 0.97(95%CI 0.95-0.99),p=.002。校正临床参数后:LAEF HR 0.97(95%CI 0.94-0.99),p=.02。STS-PROM模型C指数0.636,加入LAVImax后0.683、加入LAVImin后0.694、加入LAEF后0.700。最大和最小LA容积及LAEF的ICC范围为0.94-0.99。

临床应用与阅片要点

  • 在TAVR术前心脏CTA评估中可测量LAVImax、LAVImin并自动获取LAEF,其中LAEF可在校正临床参数后独立预测术后死亡,并可能改善基于STS-PROM的风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Cardiac CTA is required for preprocedural workup before transcatheter aortic valve replacement (TAVR) and can be used to assess functional parameters of the left atrium (LA). OBJECTIVE. We aimed to evaluate the utility of functional and volumetric LA parameters derived from cardiac CTA to predict mortality in patients with severe aortic stenosis (AS) undergoing TAVR. METHODS. This retrospective study included 175 patients with severe AS (92 men, 83 women; median age, 79.0 years) who underwent cardiac CTA for clinical pre-TAVR assessment. A postdoctoral research fellow calculated maximum and minimum LA volumes using biplane area-length measurements; these values were indexed to body surface area, and maximum and minimum LA volume index (LAVImax and LAVImin, respectively) values were calculated. The LA emptying fraction (LAEF) was automatically calculated. All-cause mortality within a 24-month follow-up period after TAVR was recorded. To identify parameters predictive of mortality, Cox regression analysis was performed, and results were summarized by hazard ratio (HR) and 95% CI. The Harrell C-index was used to assess model performance. A radiology resident repeated the measurements in a random sample of 20% (n = 35) of the cases, and interobserver agreement was computed using the intraclass correlation coefficient (ICC). RESULTS. Thirty-eight deaths (21.7%) were recorded within a median follow-up of 21 months. LAVImax (HR, 1.02 [95% CI, 1.01-1.04]; p = .01), LAVImin (HR, 1.02 [95% CI, 1.01-1.04]; p < .001), and LAEF (HR, 0.97 [95% CI, 0.95-0.99]; p = .002) were predictive of mortality in univariable analysis. After adjusting for clinical parameters, only LAEF (HR, 0.97 [95% CI, 0.94-0.99]; p = .02) independently predicted mortality. The C-index of the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) significantly increased from 0.636 to 0.683, 0.694, and 0.700 when incorporating into the model LAVImax, LAVImin, and LAEF, respectively. The ICC for maximum and minimum LA volumes and LAEF ranged from 0.94 to 0.99. CONCLUSION. LAEF derived from preprocedural cardiac CTA independently predicts mortality in patients with severe AS undergoing TAVR. CLINICAL IMPACT. Cardiac CTA-derived LA function, evaluated during pre-TAVR workup, can be used to assess preprocedural risk and may improve risk stratification in post-TAVR surveillance.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Aquino GJ, Decker JA, Schoepf UJ, et al. Utility of Functional and Volumetric Left Atrial Parameters Derived From Preprocedural Cardiac CTA in Predicting Mortality After Transcatheter Aortic Valve Replacement. AJR Am J Roentgenol. 2021. PMID: 34643107. doi:10.2214/AJR.21.26775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。